Markets › United States › NAS › CSBR

Champions Oncology Inc

NAS:CSBRHealthcarenasdaq_composite

$4.69−0.21%At closeAt close · Tue 20 Oct · ≈ AED 17.22 · Market cap $65.28M · Next earnings Tue 15 Dec

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	47.7%	51.9%	45.2%	41.4%	50.1%	48.0%	—	—
Operating margin	0.9%	1.2%	−8.3%	−13.8%	8.5%	−1.9%	−1.9%	+0.0 pts
Net margin	0.9%	1.1%	−9.9%	−14.5%	8.3%	−2.0%	−2.0%	+0.0 pts
EBITDA margin	3.8%	4.5%	−5.6%	−10.8%	11.0%	0.8%	—	—
Return on equity	4.9%	6.0%	−115.1%	382.3%	124.6%	−29.8%	−28.9%	+0.9 pts
Return on assets	1.3%	1.5%	−15.5%	−27.8%	14.5%	−4.4%	−4.4%	+0.0 pts
Return on capital employed	2.2%	3.4%	−35.4%	−150.8%	57.1%	−16.1%	—	—
Debt / equity	1.3×	1.0×	1.9×	−3.9×	1.6×	1.2×	1.1×	−3.2%
Debt / assets	34.8%	26.8%	25.1%	28.4%	18.9%	17.0%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	1.1×	1.1×	0.9×	0.6×	0.9×	1.0×	1.0×	+0.0%
Quick ratio	1.1×	1.1×	0.9×	0.6×	0.9×	1.0×	—	—
Cash ratio	0.4×	0.5×	0.5×	0.1×	0.4×	0.2×	0.2×	+0.0%
Asset turnover	1.5×	1.4×	1.6×	1.9×	1.8×	2.2×	—	—
Receivables turnover	5.9×	5.2×	6.7×	5.3×	5.1×	4.5×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—